114 Results

People

  1. Palomba
    Palomba
  2. Salles
    Salles
  3. Zelenetz
    Zelenetz
  4. Moskowitz
    Moskowitz
  5. Stuver
    Stuver
  6. Horwitz
    Horwitz
  7. Shah
    Shah
  8. Scordo
    Scordo
  9. Perales
    Perales
  10. Lin
    Lin

Groups

  1. Center for Hematologic Malignancies (114)
  2. Department of Medicine (114)
  3. GME, Medicine (114)
  4. Graduate Medical Education (114)
  5. Hematologic Malignancies, Division of (114)
  6. Lymphoma (114)
  7. Hematology-Oncology Fellows (58)
  8. Survivorship Research (55)
  9. GSK Faculty (51)
  10. Sloan Kettering Institute Postdocs (49)
  1. "Center for Hematologic Malignancies"
  2. "GME, Medicine"
  3. "Lymphoma"
Formats
  1. Meeting Abstract (71)
  2. Journal Article (22)
  3. Research Letter (9)
  4. Review (7)
  5. Editorial (3)
  6. Correspondence (2)
Groups
  1. Center for Hematologic Malignancies (114)
  2. Department of Medicine (114)
  3. GME, Medicine (114)
  4. Graduate Medical Education (114)
  5. Hematologic Malignancies, Division of (114)
  6. Lymphoma (114)

More Groups

People
  1. Maria Palomba (60)
  2. Gilles Salles (47)
  3. Andrew Zelenetz (38)
  4. Alison Moskowitz (37)
  5. Robert Stuver (36)
  6. Steven Horwitz (35)

More People

Years
  1. 2024 (5)
  2. 2023 (57)
  3. 2022 (31)
  4. 2021 (13)
  5. 2020 (2)
  6. 2016 (1)

More Years

Publications
  1. Blood (60)
  2. Journal of Clinical Oncology (6)
  3. Leukemia and Lymphoma (6)
  4. Blood Advances (5)
  5. Hematological Oncology (5)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (65)
  2. Taylor & Francis Group (7)
  3. American Society of Clinical Oncology (6)
  4. Elsevier Inc. (5)
  5. Nature Publishing Group (5)
  6. Wiley Blackwell (5)

More Publishers

Results (114)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Does BTKi improve CAR T-cell therapy in MCL?
    Editorial

    Boardman, A. P.; Palomba, M. L.
    Blood (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Impact of therapy sequence on survival outcomes among patients with relapsed or refractory mature T and NK cell neoplasms: A global retrospective cohort study
    Meeting Abstract

    Sorial, M. N.; Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Eche-Ugwu, I. J.; Duan, R.; Lei, M. M.; Miranda, E.; Chiattone, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of sequential CD19-directed therapies in relapsed and refractory large B cell lymphoma
    Meeting Abstract

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M. H.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G.; Romancik, J. T.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes for patients with classical Hodgkin lymphoma who relapse after autologous stem cell transplant in the era of novel therapies
    Meeting Abstract

    Stuver, R.; Drill, E.; Ganesan, N.; Baron, K.; Casper, E.; Chang, T.; Desai, S. H.; Falade, A. S.; Galasso, N.; Herrera, A. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of peri-transplant radiation on outcomes in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplant
    Meeting Abstract

    Baron, K.; Drill, E.; Ganesan, N.; Merryman, R. W.; Mei, M. G.; Stuver, R.; Desai, S. H.; Falade, A. S.; Iyengar, S.; Micallef, I.; more...
    Blood (2023)

    Fulltext@MSK | Save